EDGEMOND JAMES

PrivateCIK: 1636178
Location

SILVER SPRING, MD

EDGEMOND JAMES (CFO AND TREASURER) sold 34.6% of their position (10K shares) of UNITED THERAPEUTICS CORP on the open market

Open‑market sale worth $5.78M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 8 sales
InsiderEDGEMOND JAMESCIK 1636178
IssuerUNITED THERAPEUTICS CORPCIK 1082554
Officer· CFO AND TREASURER
Since Mar 2023
-10K
Net shares
Net seller
$5.78M
Total sold
8
Open market trades
0B · 8S
10
Total transactions
10K acquired · 20K disposed
Non-Derivative Transactions9

Common Stock

Direct
M · Option Exercise

Shares

+10K

Price / share

$135.42

Trade value

$1.35M

% of position

53.0%
4/9/2026
18.88K28.88K

Common Stock

Direct
S · Sale

Shares

560.00

Price / share

$574.87

Trade value

$321.93K

% of position

1.9%
4/9/2026
28.88K28.32K

Common Stock

Direct
S · Sale

Shares

1.96K

Price / share

$575.53

Trade value

$1.13M

% of position

6.9%
4/9/2026
28.32K26.36K

Common Stock

Direct
S · Sale

Shares

1.59K

Price / share

$576.63

Trade value

$914.53K

% of position

6.0%
4/9/2026
26.36K24.77K

Common Stock

Direct
S · Sale

Shares

1.62K

Price / share

$577.77

Trade value

$934.25K

% of position

6.5%
4/9/2026
24.77K23.16K

Common Stock

Direct
S · Sale

Shares

1.14K

Price / share

$578.52

Trade value

$658.94K

% of position

4.9%
4/9/2026
23.16K22.02K

Common Stock

Direct
S · Sale

Shares

1.22K

Price / share

$579.75

Trade value

$709.61K

% of position

5.6%
4/9/2026
22.02K20.79K

Common Stock

Direct
S · Sale

Shares

1.76K

Price / share

$580.64

Trade value

$1.02M

% of position

8.4%
4/9/2026
20.79K19.04K

Common Stock

Direct
S · Sale

Shares

162.00

Price / share

$582.30

Trade value

$94.33K

% of position

0.9%
4/9/2026
19.04K18.88K
Total

Net shares

+0.00

Net value

-$4.42M

Derivative Transactions1

Stock Option

Direct
M · Option Exercise
Converts to

Common Stock

10K shares

Shares

10K

Strike price

135.42

Held after

102.50K

Exercisable

4/9/2026
EDGEMOND JAMES — Insider Transaction (Form 4) Filed Apr 10, 2026 | Finecho